{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T17:26:01Z","timestamp":1785432361372,"version":"3.56.0"},"posted":{"date-parts":[[2025,6,30]]},"group-title":"Bioengineering","reference-count":99,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R21CA259158"],"award-info":[{"award-number":["R21CA259158"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R37CA291976"],"award-info":[{"award-number":["R37CA291976"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P30GM145398"],"award-info":[{"award-number":["P30GM145398"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P30GM154633"],"award-info":[{"award-number":["P30GM154633"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"award":["RSG-23-1149466-01-CDP"],"award-info":[{"award-number":["RSG-23-1149466-01-CDP"]}],"id":[{"id":"https:\/\/ror.org\/02e463172","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,6,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>High-grade serous tumors are immunologically cold, characterized by limited immune cell infiltration and reduced clinical outcome, primarily due to hypoxia and extensive extracellular matrix remodeling that disrupt tumor-stromal-immune interactions. However, current experimental models fail to fully capture oxygen and matrix microenvironmental features, limiting progress in understanding tumor-immune dynamics and developing effective treatments. Here, we demonstrate that patient-derived tumor-immune tunable models, mimicking physiologically relevant oxygen levels and extracellular matrix remodeling, recapitulate the hypoxia-induced stromal\/matrix dysregulation, which causes impaired immune infiltration, and enable dissecting targeted opportunities via TGF-\u03b2 signaling. The models integrate cancer cells co-cultured with cancer-associated fibroblasts and exposed to immune cells as multi-culture or challenged them to infiltrate into a 3D model bioengineered with autologous plasma from the matching patient or onto decellularized human ovaries. By bioengineering physiologically relevant oxygen levels of hypoxic tumors and physoxic ovaries, we uncovered that intratumoral hypoxia acts as a friend and a foe, causing hypoxia-induced stromal-driven impaired immune infiltration but enhancing the activation and cytotoxicity of CD8+ T cells. We also showed that targeting TGF-\u03b2 signaling reversed the hypoxia-induced stromal-driven impaired immune infiltration. These human-relevant tunable models may aid the development of targeted therapies to turn immunologically cold tumors into hot ones.<\/jats:p>","DOI":"10.1101\/2025.06.23.661098","type":"posted-content","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T18:15:16Z","timestamp":1751480116000},"source":"Crossref","is-referenced-by-count":0,"title":["Recapitulating physiologically relevant oxygen levels and extracellular matrix remodeling in patient-derived tumor-immune tunable models reveal targeting opportunities for immunologically cold high-grade serous tumors"],"prefix":"10.64898","author":[{"given":"Simona","family":"Plesselova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailey","family":"Axemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Calar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oduduabasi","family":"Isaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Wollman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somshuvra","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5338-084X","authenticated-orcid":false,"given":"Etienne Z.","family":"Gnimpieba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darci M.","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congzhou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5953-1197","authenticated-orcid":false,"given":"Pilar","family":"de la Puente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2025070215151243000_2025.06.23.661098v1.1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc4019"},{"key":"2025070215151243000_2025.06.23.661098v1.2","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-023-05026-3"},{"key":"2025070215151243000_2025.06.23.661098v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.07.004"},{"key":"2025070215151243000_2025.06.23.661098v1.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020177"},{"key":"2025070215151243000_2025.06.23.661098v1.5","doi-asserted-by":"publisher","DOI":"10.1177\/1758835920967241"},{"key":"2025070215151243000_2025.06.23.661098v1.6","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.3290"},{"key":"2025070215151243000_2025.06.23.661098v1.7","doi-asserted-by":"crossref","unstructured":"Boudreau, J.E . Immune-molecular interactions in high-grade serous ovarian cancer distinguish long-term survivors. J Clin Invest 134 (2024).","DOI":"10.1172\/JCI184790"},{"key":"2025070215151243000_2025.06.23.661098v1.8","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01230-9"},{"key":"2025070215151243000_2025.06.23.661098v1.9","unstructured":"Nelson, B.H. et al. Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer. J Clin Invest 134 (2024)."},{"key":"2025070215151243000_2025.06.23.661098v1.10","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-019-1051-3"},{"key":"2025070215151243000_2025.06.23.661098v1.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115425"},{"key":"2025070215151243000_2025.06.23.661098v1.12","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201102147"},{"key":"2025070215151243000_2025.06.23.661098v1.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215839"},{"key":"2025070215151243000_2025.06.23.661098v1.14","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2013-5016"},{"key":"2025070215151243000_2025.06.23.661098v1.15","doi-asserted-by":"crossref","unstructured":"Zhang, M. , Chen, Z. , Wang, Y. , Zhao, H. & Du, Y . The Role of Cancer-Associated Fibroblasts in Ovarian Cancer. Cancers (Basel ) 14 (2022).","DOI":"10.3390\/cancers14112637"},{"key":"2025070215151243000_2025.06.23.661098v1.16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-8-223"},{"key":"2025070215151243000_2025.06.23.661098v1.17","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-020-00646-x"},{"key":"2025070215151243000_2025.06.23.661098v1.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-021-00652-9"},{"key":"2025070215151243000_2025.06.23.661098v1.19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38093-5"},{"key":"2025070215151243000_2025.06.23.661098v1.20","doi-asserted-by":"crossref","unstructured":"Klemba, A. et al. Hypoxia-Mediated Decrease of Ovarian Cancer Cells Reaction to Treatment: Significance for Chemo- and Immunotherapies. Int J Mol Sci 21 (2020).","DOI":"10.3390\/ijms21249492"},{"key":"2025070215151243000_2025.06.23.661098v1.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.08.071"},{"key":"2025070215151243000_2025.06.23.661098v1.22","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2018180666"},{"key":"2025070215151243000_2025.06.23.661098v1.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14052-x"},{"key":"2025070215151243000_2025.06.23.661098v1.24","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24601"},{"key":"2025070215151243000_2025.06.23.661098v1.25","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20130676"},{"key":"2025070215151243000_2025.06.23.661098v1.26","doi-asserted-by":"publisher","DOI":"10.1530\/jrf.0.0330011"},{"key":"2025070215151243000_2025.06.23.661098v1.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)55635-0"},{"key":"2025070215151243000_2025.06.23.661098v1.28","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(92)90241-P"},{"key":"2025070215151243000_2025.06.23.661098v1.29","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.01040"},{"key":"2025070215151243000_2025.06.23.661098v1.30","doi-asserted-by":"crossref","unstructured":"Calar, K. , Plesselova, S. , Bhattacharya, S. , Jorgensen, M. & de la Puente, P . Human Plasma-Derived 3D Cultures Model Breast Cancer Treatment Responses and Predict Clinically Effective Drug Treatment Concentrations. Cancers (Basel ) 12 (2020).","DOI":"10.3390\/cancers12071722"},{"key":"2025070215151243000_2025.06.23.661098v1.31","first-page":"4156187","article-title":"Identification of Hypoxia Signature to Assess the Tumor Immune Microenvironment and Predict Prognosis in Patients with Ovarian Cancer","volume":"2021","year":"2021","journal-title":"Int J Endocrinol"},{"key":"2025070215151243000_2025.06.23.661098v1.32","doi-asserted-by":"crossref","unstructured":"Mallikarjuna, P. , Zhou, Y. & Landstrom, M . The Synergistic Cooperation between TGF-beta and Hypoxia in Cancer and Fibrosis. Biomolecules 12 (2022).","DOI":"10.3390\/biom12050635"},{"key":"2025070215151243000_2025.06.23.661098v1.33","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-018-0007-0"},{"key":"2025070215151243000_2025.06.23.661098v1.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.07.036"},{"key":"2025070215151243000_2025.06.23.661098v1.35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19408-2"},{"key":"2025070215151243000_2025.06.23.661098v1.36","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0556-6"},{"key":"2025070215151243000_2025.06.23.661098v1.37","doi-asserted-by":"crossref","unstructured":"Xue, B. et al. A Novel Hydrogel-Based 3D In Vitro Tumor Panel of 30 PDX Models Incorporates Tumor, Stromal and Immune Cell Compartments of the TME for the Screening of Oncology and Immuno-Therapies. Cells 12 (2023).","DOI":"10.3390\/cells12081145"},{"key":"2025070215151243000_2025.06.23.661098v1.38","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1189"},{"key":"2025070215151243000_2025.06.23.661098v1.39","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-017-0011-9"},{"key":"2025070215151243000_2025.06.23.661098v1.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117601"},{"key":"2025070215151243000_2025.06.23.661098v1.41","doi-asserted-by":"crossref","unstructured":"Synowiec, A. et al. Hypoxia, but Not Normoxia, Reduces Effects of Resveratrol on Cisplatin Treatment in A2780 Ovarian Cancer Cells: A Challenge for Resveratrol Use in Anticancer Adjuvant Cisplatin Therapy. Int J Mol Sci 24 (2023).","DOI":"10.3390\/ijms24065715"},{"key":"2025070215151243000_2025.06.23.661098v1.42","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-022-03495-6"},{"key":"2025070215151243000_2025.06.23.661098v1.43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18794-x"},{"key":"2025070215151243000_2025.06.23.661098v1.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2024.09.001"},{"key":"2025070215151243000_2025.06.23.661098v1.45","doi-asserted-by":"crossref","unstructured":"Belotti, Y. , Lim, E.H. & Lim, C.T . The Role of the Extracellular Matrix and Tumor-Infiltrating Immune Cells in the Prognostication of High-Grade Serous Ovarian Cancer. Cancers (Basel ) 14 (2022).","DOI":"10.3390\/cancers14020404"},{"key":"2025070215151243000_2025.06.23.661098v1.46","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dead122"},{"key":"2025070215151243000_2025.06.23.661098v1.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106381"},{"key":"2025070215151243000_2025.06.23.661098v1.48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15583-3"},{"key":"2025070215151243000_2025.06.23.661098v1.49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60395-z"},{"key":"2025070215151243000_2025.06.23.661098v1.50","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-2616"},{"key":"2025070215151243000_2025.06.23.661098v1.51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2007.03565.x"},{"key":"2025070215151243000_2025.06.23.661098v1.52","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4569"},{"key":"2025070215151243000_2025.06.23.661098v1.53","doi-asserted-by":"crossref","unstructured":"Axemaker, H. , et al. Normal Uterine Fibroblast Are Reprogramed into Ovarian Cancer-Associated Fibroblasts by Ovarian Tumor-derived Conditioned Media. bioRxiv (2023).","DOI":"10.1101\/2023.09.29.560158"},{"key":"2025070215151243000_2025.06.23.661098v1.54","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0196"},{"key":"2025070215151243000_2025.06.23.661098v1.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.100553"},{"key":"2025070215151243000_2025.06.23.661098v1.56","first-page":"2811","article-title":"Influence of hypoxia inducible factors on the immune microenvironment in ovarian cancer","volume":"34","year":"2014","journal-title":"Anticancer Res"},{"key":"2025070215151243000_2025.06.23.661098v1.57","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1450751"},{"key":"2025070215151243000_2025.06.23.661098v1.58","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-20-0561"},{"key":"2025070215151243000_2025.06.23.661098v1.59","doi-asserted-by":"crossref","unstructured":"Liikanen, I. et al. Hypoxia-inducible factor activity promotes antitumor effector function and tissue residency by CD8+ T cells. J Clin Invest 131 (2021).","DOI":"10.1172\/JCI143729"},{"key":"2025070215151243000_2025.06.23.661098v1.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.10.038"},{"key":"2025070215151243000_2025.06.23.661098v1.61","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0312-6"},{"key":"2025070215151243000_2025.06.23.661098v1.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2025.01.010"},{"key":"2025070215151243000_2025.06.23.661098v1.63","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-024-05826-1"},{"key":"2025070215151243000_2025.06.23.661098v1.64","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2024.1434617"},{"key":"2025070215151243000_2025.06.23.661098v1.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2020.118663"},{"key":"2025070215151243000_2025.06.23.661098v1.66","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06070-9"},{"key":"2025070215151243000_2025.06.23.661098v1.67","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01764-w"},{"key":"2025070215151243000_2025.06.23.661098v1.68","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0356-4"},{"key":"2025070215151243000_2025.06.23.661098v1.69","doi-asserted-by":"crossref","unstructured":"Zhang, Q. et al. LY2157299 Monohydrate, a TGF-betaR1 Inhibitor, Suppresses Tumor Growth and Ascites Development in Ovarian Cancer. Cancers (Basel ) 10 (2018).","DOI":"10.3390\/cancers10080260"},{"key":"2025070215151243000_2025.06.23.661098v1.70","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cytogfr.2023.04.001","article-title":"TGF-beta mediated drug resistance in solid cancer","volume":"71-72","year":"2023","journal-title":"Cytokine Growth Factor Rev"},{"key":"2025070215151243000_2025.06.23.661098v1.71","doi-asserted-by":"crossref","unstructured":"Melisi, D. et al. Safety and activity of the TGFbeta receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer. J Immunother Cancer 9 (2021).","DOI":"10.1136\/jitc-2020-002068"},{"key":"2025070215151243000_2025.06.23.661098v1.72","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-18-0850"},{"key":"2025070215151243000_2025.06.23.661098v1.73","doi-asserted-by":"crossref","unstructured":"Peterson, J.M. et al. Galunisertib Exerts Antifibrotic Effects on TGF-beta-Induced Fibroproliferative Dermal Fibroblasts. Int J Mol Sci 23 (2022).","DOI":"10.3390\/ijms23126689"},{"key":"2025070215151243000_2025.06.23.661098v1.74","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00436-9"},{"key":"2025070215151243000_2025.06.23.661098v1.75","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13945"},{"key":"2025070215151243000_2025.06.23.661098v1.76","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24562"},{"key":"2025070215151243000_2025.06.23.661098v1.77","doi-asserted-by":"publisher","DOI":"10.1038\/nature25501"},{"key":"2025070215151243000_2025.06.23.661098v1.78","doi-asserted-by":"publisher","DOI":"10.1038\/nature25492"},{"key":"2025070215151243000_2025.06.23.661098v1.79","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01744-8"},{"key":"2025070215151243000_2025.06.23.661098v1.80","first-page":"5329","article-title":"2nd, Sabzevari, A., Schlom, J. & Greiner","volume":"40","year":"2020","journal-title":"J.W. The Development of Next-generation PBMC Humanized Mice for Preclinical Investigation of Cancer Immunotherapeutic Agents. Anticancer Res"},{"key":"2025070215151243000_2025.06.23.661098v1.81","first-page":"15 21 11","article-title":"Creation of \u201chumanized\u201d mice to study human immunity","volume":"15","year":"2008","journal-title":"Curr Protoc Immunol"},{"key":"2025070215151243000_2025.06.23.661098v1.82","doi-asserted-by":"crossref","first-page":"617","DOI":"10.12688\/f1000research.10990.1","article-title":"Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation","volume":"6","year":"2017","journal-title":"F1000Res"},{"key":"2025070215151243000_2025.06.23.661098v1.83","doi-asserted-by":"publisher","DOI":"10.1038\/nri2216"},{"key":"2025070215151243000_2025.06.23.661098v1.84","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-023-02471-z"},{"key":"2025070215151243000_2025.06.23.661098v1.85","doi-asserted-by":"crossref","unstructured":"Plesselova, S. et al. Multicompartmentalized Microvascularized Tumor-on-a-Chip to Study Tumor-Stroma Interactions and Drug Resistance in Ovarian Cancer. Cellular and Molecular Bioengineering (2024).","DOI":"10.1101\/2024.05.29.596456"},{"key":"2025070215151243000_2025.06.23.661098v1.86","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00544-0"},{"key":"2025070215151243000_2025.06.23.661098v1.87","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4690"},{"key":"2025070215151243000_2025.06.23.661098v1.88","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14049"},{"key":"2025070215151243000_2025.06.23.661098v1.89","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.05.031"},{"key":"2025070215151243000_2025.06.23.661098v1.90","doi-asserted-by":"crossref","unstructured":"Becht, E. et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat Biotechnol (2018).","DOI":"10.1038\/nbt.4314"},{"key":"2025070215151243000_2025.06.23.661098v1.91","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-0969-x"},{"key":"2025070215151243000_2025.06.23.661098v1.92","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0276-y"},{"key":"2025070215151243000_2025.06.23.661098v1.93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206785"},{"key":"2025070215151243000_2025.06.23.661098v1.94","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-00991-4"},{"key":"2025070215151243000_2025.06.23.661098v1.95","doi-asserted-by":"crossref","unstructured":"Izzi, V. , Davis, M.N. & Naba, A . Pan-Cancer Analysis of the Genomic Alterations and Mutations of the Matrisome. Cancers (Basel ) 12 (2020).","DOI":"10.3390\/cancers12082046"},{"key":"2025070215151243000_2025.06.23.661098v1.96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.951582"},{"key":"2025070215151243000_2025.06.23.661098v1.97","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06654-8"},{"key":"2025070215151243000_2025.06.23.661098v1.98","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109165"},{"key":"2025070215151243000_2025.06.23.661098v1.99","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.06.23.661098","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T09:02:01Z","timestamp":1768467721000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.06.23.661098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":99,"URL":"https:\/\/doi.org\/10.1101\/2025.06.23.661098","relation":{},"subject":[],"published":{"date-parts":[[2025,6,30]]},"subtype":"preprint"}}